Literature DB >> 6370486

Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread.

R C Baron, J B McCormick, O A Zubeir.   

Abstract

Between 31 July and 6 October 1979, 34 cases of Ebola virus disease (22 of which were fatal) occurred among five families in a rural district of southern Sudan; the disease was introduced into four of the families from a local hospital. Chains of secondary spread within the family units, accounting for 29 cases resulted from direct physical contact with an infected person. Among all persons with such contact in the family setting, those who provided nursing care had a 5.1-fold increased risk of infection, emphasizing the importance of intimate contact in the spread of this disease. The absence of illness among persons who were exposed to cases in confined spaces, but without physical contact, confirmed previous impressions that there is no risk of airborne transmission. While the ecology of Ebola virus is unknown, the presence of anti-Ebola antibodies in the sera of 18% of persons who were unassociated with the outbreak suggests that the region is an endemic focus of Ebola virus activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6370486      PMCID: PMC2536233     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  9 in total

1.  A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972.

Authors:  T P Monath; P E Mertens; R Patton; C R Moser; J J Baum; L Pinneo; G W Gary; R E Kissling
Journal:  Am J Trop Med Hyg       Date:  1973-11       Impact factor: 2.345

2.  Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria.

Authors:  D E Carey; G E Kemp; H A White; L Pinneo; R F Addy; A L Fom; G Stroh; J Casals; B E Henderson
Journal:  Trans R Soc Trop Med Hyg       Date:  1972       Impact factor: 2.184

3.  Marburg-virus disease in Kenya.

Authors:  D H Smith; B K Johnson; M Isaacson; R Swanapoel; K M Johnson; M Killey; A Bagshawe; T Siongok; W K Keruga
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

4.  Indirect immunofluorescence for the diagnosis of Lassa fever infection.

Authors:  H Wulff; J V Lange
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

5.  Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire.

Authors:  K M Johnson; J V Lange; P A Webb; F A Murphy
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

6.  Isolation of Marburg-like virus from a case of haemorrhagic fever in Zaire.

Authors:  S Pattyn; G van der Groen; W Jacob; P Piot; G Courteille
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

7.  Viral haemorrhagic fever in southern Sudan and northern Zaire. Preliminary studies on the aetiological agent.

Authors:  E T Bowen; G Lloyd; W J Harris; G S Platt; A Baskerville; E E Vella
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

8.  Biologic differences between strains of Ebola virus from Zaire and Sudan.

Authors:  J B McCormick; S P Bauer; L H Elliott; P A Webb; K M Johnson
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

9.  Nosocomial outbreak of viral hemorrhagic fever caused by Crimean Hemorrhagic fever-Congo virus in Pakistan, January 1976.

Authors:  M I Burney; A Ghafoor; M Saleen; P A Webb; J Casals
Journal:  Am J Trop Med Hyg       Date:  1980-09       Impact factor: 2.345

  9 in total
  104 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

Review 2.  Persistence of category A select agents in the environment.

Authors:  Ryan Sinclair; Stephanie A Boone; David Greenberg; Paul Keim; Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2007-12-07       Impact factor: 4.792

3.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

Review 4.  Ebola virus transmission.

Authors:  W L Irving
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

Review 5.  Achieving cross-reactivity with pan-ebolavirus antibodies.

Authors:  Liam B King; Jacob C Milligan; Brandyn R West; Sharon L Schendel; Erica Ollmann Saphire
Journal:  Curr Opin Virol       Date:  2019-03-15       Impact factor: 7.090

6.  Molecular evolution of viruses of the family Filoviridae based on 97 whole-genome sequences.

Authors:  Serena A Carroll; Jonathan S Towner; Tara K Sealy; Laura K McMullan; Marina L Khristova; Felicity J Burt; Robert Swanepoel; Pierre E Rollin; Stuart T Nichol
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

7.  Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit.

Authors:  P S C Rees; L E M Lamb; T C Nicholson-Roberts; C N Ardley; M S Bailey; D E Hinsley; T E Fletcher; S J Dickson
Journal:  Intensive Care Med       Date:  2015-03-12       Impact factor: 17.440

8.  High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon.

Authors:  Pierre Becquart; Nadia Wauquier; Tanel Mahlakõiv; Dieudonné Nkoghe; Cindy Padilla; Marc Souris; Benjamin Ollomo; Jean-Paul Gonzalez; Xavier De Lamballerie; Mirdad Kazanji; Eric M Leroy
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

9.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

10.  Ebola Virus Shedding and Transmission: Review of Current Evidence.

Authors:  Pauline Vetter; William A Fischer; Manuel Schibler; Michael Jacobs; Daniel G Bausch; Laurent Kaiser
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.